Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-30
DOI
10.1038/s41401-018-0081-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial
- (2018) Jose M. Trigo et al. PLoS One
- Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor
- (2017) Francesco Spinelli et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
- (2017) C E Wiers et al. MOLECULAR PSYCHIATRY
- The endocannabinoid system as a target for addiction treatment: Trials and tribulations
- (2017) Matthew E. Sloan et al. NEUROPHARMACOLOGY
- The endocannabinoid system as a target for novel anxiolytic drugs
- (2017) Sachin Patel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine
- (2017) Abhishekh H. Ashok et al. JAMA Psychiatry
- A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography
- (2016) Changning Wang et al. ACS Chemical Neuroscience
- FAAHGene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence
- (2016) Primavera A. Spagnolo et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III
- (2016) Deborah S. Hasin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB
- (2016) Isabelle Boileau et al. BIOLOGICAL PSYCHIATRY
- Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
- (2016) Mohini Ranganathan et al. BIOLOGICAL PSYCHIATRY
- Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
- (2016) Yoan Mihov BIOLOGICAL PSYCHIATRY
- Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
- (2016) Frances R. Levin et al. DRUG AND ALCOHOL DEPENDENCE
- Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
- (2016) Jose M. Trigo et al. DRUG AND ALCOHOL DEPENDENCE
- Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
- (2016) Charles W Schindler et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoid concentrations in hair are associated with PTSD symptom severity
- (2016) Sarah Wilker et al. PSYCHONEUROENDOCRINOLOGY
- Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
- (2016) Arianna Marconi et al. SCHIZOPHRENIA BULLETIN
- Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [18F]MK-9470 PET study
- (2016) J Ceccarini et al. Translational Psychiatry
- The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans
- (2015) Jose A. Cortes-Briones et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- In vivoimaging of the cannabinoid CB1receptor with positron emission tomography
- (2015) J Hirvonen CLINICAL PHARMACOLOGY & THERAPEUTICS
- Medical Marijuana
- (2015) Deepak Cyril D'Souza et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blocking of Fatty Acid Amide Hydrolase Activity with PF-04457845 in Human Brain: A Positron Emission Tomography Study with the Novel Radioligand [11C]CURB
- (2015) Isabelle Boileau et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Imaging the Cannabinoid CB1 Receptor in Humans with [11C] OMAR: Assessment of Kinetic Analysis Methods, Test–Retest Reproducibility, and Gender Differences
- (2015) Marc D Normandin et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB
- (2015) Isabelle Boileau et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
- (2015) Rakesh Jetly et al. PSYCHONEUROENDOCRINOLOGY
- Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
- (2015) Huynh Giao Ly et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- FAAH genetic variation enhances fronto-amygdala function in mouse and human
- (2015) Iva Dincheva et al. Nature Communications
- Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol
- (2015) Nina L. Cluny et al. PLoS One
- Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa
- (2014) Alessio Maria Monteleone et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
- (2014) Cecilia Hillard et al. CURRENT PHARMACEUTICAL DESIGN
- Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence
- (2014) J. Ceccarini et al. JOURNAL OF NEUROSCIENCE
- Mechanisms of Exercise-Induced Hypoalgesia
- (2014) Kelli F. Koltyn et al. JOURNAL OF PAIN
- Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors
- (2014) Robert H Pietrzak et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognosis of schizophrenia in persons with and without a history of cannabis use
- (2014) E. Manrique-Garcia et al. PSYCHOLOGICAL MEDICINE
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- [18F]MK-9470 PET measurement of cannabinoid CB1receptor availability in chronic cannabis users
- (2013) Jenny Ceccarini et al. ADDICTION BIOLOGY
- Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
- (2013) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
- (2013) Rawaha Ahmad et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?
- (2013) Bernard Le Foll et al. MEDICAL HYPOTHESES
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
- (2013) Jenny Ceccarini et al. NEUROIMAGE
- Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
- (2013) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
- (2013) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Positron Emission Tomography Shows Elevated Cannabinoid CB1Receptor Binding in Men with Alcohol Dependence
- (2012) Alexander Neumeister et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
- (2012) Ryan Vandrey et al. DRUG AND ALCOHOL DEPENDENCE
- Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography
- (2012) J Hirvonen et al. MOLECULAR PSYCHIATRY
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
- (2012) O Gunduz-Cinar et al. MOLECULAR PSYCHIATRY
- Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
- (2012) Andrea Dlugos et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Obesity and Cannabis Use: Results From 2 Representative National Surveys
- (2011) Yann Le Strat et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa
- (2011) Nathalie Gérard et al. BIOLOGICAL PSYCHIATRY
- In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis
- (2011) K. Goffin et al. BRAIN
- Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
- (2011) Frances R. Levin et al. DRUG AND ALCOHOL DEPENDENCE
- Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients
- (2011) Bart J. Van der Schueren et al. HEADACHE
- Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
- (2011) B Gatta-Cherifi et al. INTERNATIONAL JOURNAL OF OBESITY
- Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response
- (2011) M. N. Hill et al. JOURNAL OF NEUROSCIENCE
- Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
- (2011) J Hirvonen et al. MOLECULAR PSYCHIATRY
- Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
- (2011) Zheng-Xiong Xi et al. NATURE NEUROSCIENCE
- Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
- (2011) Koen Van Laere et al. NEUROBIOLOGY OF AGING
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Intense exercise increases circulating endocannabinoid and BDNF levels in humans—Possible implications for reward and depression
- (2011) E. Heyman et al. PSYCHONEUROENDOCRINOLOGY
- Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
- (2010) Eric J Topol et al. LANCET
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography
- (2010) Alan A. Wilson et al. NUCLEAR MEDICINE AND BIOLOGY
- Review: Functional dyspepsia
- (2010) Rita Brun et al. Therapeutic Advances in Gastroenterology
- CB1 Receptor Blockade Decreases Ethanol Intake and Associated Neurochemical Changes in Fawn-Hooded Rats
- (2009) Teresa FemenÃa et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
- (2009) Vincenzo Di Marzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands
- (2009) G. E. Terry et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
- (2009) Garth E. Terry et al. NEUROIMAGE
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- (2009) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers
- (2009) David Ted George et al. PSYCHOPHARMACOLOGY
- Divergent Effects of Genetic Variation in Endocannabinoid Signaling on Human Threat- and Reward-Related Brain Function
- (2008) Ahmad R. Hariri et al. BIOLOGICAL PSYCHIATRY
- Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
- (2008) Andrew Horti et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence
- (2008) Michael Soyka et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant
- (2008) Zuzana Justinova et al. NEUROPSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now